NATURALISTIC COURSE OF MAJOR DEPRESSIVE DISORDER PREDICTED BY CLINICAL AND STRUCTURAL NEUROIMAGING DATA: A 5-YEAR FOLLOW-UP

Depression and Anxiety

Volumn 33, Issue 11, 2016, Pages 1055-1064

  Serra Blasco, Maria ^a   de Diego Adeliño, Javier ^a   Vives Gilabert, Yolanda ^b   Trujols, Joan ^a   Puigdemont, Dolors ^a   Carceller Sindreu, Mar ^a   Pérez, Victor ^a,c   Álvarez, Enric ^a   Portella, Maria J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INNDACYT   (Spain)

^c Neuropsychiatric and Addiction Institute   (Spain)

Author keywords

biological markers; brain imaging neuroimaging; depression; mood disorders; treatment resistance

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REMISSION; STRUCTURAL NEUROIMAGING;

EID: 84966601480     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22522     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed. In: American Psychiatric Association, editor. Washington, DC: American Psychiatric Association; 2000.
2. Richards D. Prevalence and clinical course of depression: a review. Clin Psychol Rev 2011;31:1117–1125.
3. Papakostas GI, Petersen T, Mahal Y, et al. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004;26:13–17.
4. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005;162:1171–1178.
5. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97–108.
6. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501–1504.
7. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49(10):809–816.
8. Eaton W, Shao H, Nestadt G, Lee BH, Bienvenu OJ, Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008;65(5):513–520.
9. Atkinson L, Sankar A, Adams TM, Fu CHY. Recent advances in neuroimaging of mood disorders: structural and functional neural correlates of depression, changes with therapy, and potential for clinical biomarkers. Curr Treat Options Psychiatry 2014;1:278–293.
10. Serra-Blasco M, Portella MJ, Gómez-Ansón B, et al. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br J Psychiatry 2013;202:434–440.
11. Yucel K, McKinnon MC, Chahal R, et al. Anterior cingulate volumes in never-treated patients with major depressive disorder. Neuropsychopharmacology 2008;33:3157–3163.
12. de Diego-Adeliño J, Pires P, Gómez-Ansón B, et al. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol Med 2014;44:1171–1182.
13. Fu CHY, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 2013;52:75–83.
14. Frodl T, Jäger M, Smajstrlova I, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 2008;33:423–430.
15. Frodl T, Jäger M, Born C, et al. Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course. Psychiatry Res 2008;163:76–83.
16. Schmaal L, Marquand AF, Rhebergen D, et al. Predicting the naturalistic course of major depressive disorder using clinical and multimodal neuroimaging information: a multivariate pattern recognition study. Biol Psychiatry 2015;78:278–286.
17. Puigdemont D, Pérez-Egea R, Portella MJ, et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2012;15:121–133.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
19. Hassel S, Almeida JR, Kerr N, et al. Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord 2008;10:916–927.
20. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 1):10–17.
21. Roy-Byrne P, Post RM, Uhde TW, et al. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 1985;317:1–34.
22. Mathworks. 2011. Global Optimization Toolbox: User's Guide (r2011b). Retrieved November 10, 2011 from www.mathworks.com/help/pdf_doc/gads/gads_tb.pdf.
23. Ashburner J. VBM Tutorial; 2010:1–14.
24. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113.
25. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9(2):179–194.
26. Fischl B. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14(1):11–22.
27. Korgaonkar MS, Williams LM, Song YJ, et al. Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder. Br J Psychiatry 2014;205:321–328.
28. MacQueen GM. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:343–349.
29. Irion KL, Muly S, Hochhegger B, Marchiori E. Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry 2013;170:446.
30. Lisiecka D, Meisenzahl E, Scheuerecker J, et al. Neural correlates of treatment outcome in major depression. Int J Neuropsychopharmacol 2011;14:521–534.
31. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830–843.
32. Kennedy SH, Evans KR, Krüger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899–905.
33. Siegle GJ, Carter CS, Thase ME. Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 2006;163:735–738.
34. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651–660.
35. Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008;13:663–681.
36. Hamani C, Mayberg H, Stone S, et al. The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011;69:301–308.
37. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011;36:183–206.
38. Chen C-H, Ridler K, Suckling J, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62:407–414.
39. Fujino J, Yamasaki N, Miyata J, et al. Anterior cingulate volume predicts response to cognitive behavioral therapy in major depressive disorder. J Affect Disord 2015;174:397–399.
40. Sudheimer KD, Abelson JL, Taylor SF, et al. Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness. Neuropsychopharmacology 2013;38:826–845.
41. Treadway MT, Grant MM, Ding Z, et al. Early adverse events, HPA activity and rostral anterior cingulate volume in MDD. PLoS One 2009;4:e4887.
42. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000;886:172–189.